Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123212 · ClinicalTrials.gov registry record · NA
Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
A NA study, sponsored by National Opinion Research Center.
- Completed
- Registry status
- NA
- Development phase
- 29,607
- Enrollment target
NCT02123212: Completed NA study, sponsored by National Opinion Research Center.
NCT02123212 is a NA study that has completed, run by National Opinion Research Center. The registered enrollment target is 29,607 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2010% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123212, a NA study, has completed, sponsored by National Opinion Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29,607 participants
- Enrollment target
Study Summary
The Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C (BEST-C) compares the effectiveness of the birth cohort HCV screening strategy with the current risk-based screening approach to detect previous unidentified persons with viral hepatitis C who receive health care in primary systems. The study involved three clinical sites, The University of Alabama, Birmingham; The Henry Ford Health System; and the Mount Sinai Medical Center, each of which developed an independent intervention to experimentally compare the number of positive Hepatitis C Virus (HCV) diagnoses found using the birth-cohort screening approach with that found using traditional risk-based screening, or standard of care strategies. Birth cohort testing is defined as the systematic recommendation of HCV antibody testing to any persons born during the years of 1945 to 1965 who do not have clinically documented evidence of a prior antibody test without regards to the patient's stated risk of exposure to the virus.
Primary Outcome
Positive diagnosis on a Hepatitis C test
Interventions
- OTHER Mailer
- OTHER In-person recruitment
- OTHER EHR Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29,607 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT02123212 record still lists
NCT02123212 is an interventional study that assigns participants to a tested intervention. Its 29,607 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2010% higher).
The record links to 0 conditions, and to 3 interventions - of which Mailer is the first listed.
NCT02123212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02123212 about?
NCT02123212 is a clinical study titled "Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C". The Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C (BEST-C) compares the effectiveness of the birth cohort HCV screening strategy with the current risk-based screening approach to detect previous unidentified persons with viral hepatitis C who receive health care in primary...
What is the current status of trial NCT02123212?
This trial is currently completed. It is a NA study. The enrollment target is 29,607 participants. The study started on 2013-02. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02123212?
The interventions under investigation include: Mailer (OTHER), In-person recruitment (OTHER), EHR Alert (OTHER).
Who is sponsoring clinical trial NCT02123212?
This trial is sponsored by National Opinion Research Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02123212's enrollment target sits among peer trials
29,607 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia